Prognostic Value of KRAS G12C in Advanced Non-Small Cell Lung Cancer With High PD-L1 Expression Treated With Upfront Immunotherapy: A Systematic Review and Meta-Analysis. Swiss Med Wkly 2024, 154 (7), 3695. https://doi.org/10.57187/s.3695.